首页> 美国卫生研究院文献>International Journal of Molecular Sciences >N-Glycoprofiling Analysis for Carbohydrate Composition and Site-Occupancy Determination in a Poly-Glycosylated Protein: Human Thyrotropin of Different Origins
【2h】

N-Glycoprofiling Analysis for Carbohydrate Composition and Site-Occupancy Determination in a Poly-Glycosylated Protein: Human Thyrotropin of Different Origins

机译:糖基化蛋白的N-糖基分析分析和位点占有率测定:不同来源的人促甲状腺素

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Human thyrotropin (hTSH) is a glycoprotein with three potential glycosylation sites: two in the α-subunit and one in the β-subunit. These sites are not always occupied and occupancy is frequently neglected in glycoprotein characterization, even though it is related to folding, trafficking, initiation of inflammation and host defense, as well as congenital disorders of glycosylation (CDG). For the first time N-glycoprofiling analysis was applied to the site-occupancy determination of two native pituitary hTSH, in comparison with three recombinant preparations of hTSH, a widely used biopharmaceutical. A single methodology provided the: (i) average N-glycan mass; (ii) mass fraction of each monosaccharide and of sulfate; and (iii) percent carbohydrate. The results indicate that the occupancy (65%–87%) and carbohydrate mass (12%–19%) can be up to 34%–57% higher in recombinant hormones. The average glycan mass is 24% lower in pituitary hTSH and contains ~3-fold fewer moles of galactose (p < 0.005) and sialic acid (p < 0.01). One of the two native preparations, which had the smallest glycan mass together with the lowest occupancy and GalNAc, sulfate, Gal and sialic acid contents, also presented the lowest in vivo bioactivity and circulatory half-life. The methodology described, comparing a recombinant biopharmaceutical to its native equivalent, can be applied to any physiologically or clinical relevant glycoprotein.
机译:人促甲状腺激素(hTSH)是一种具有三个潜在糖基化位点的糖蛋白:两个位于α亚基中,一个位于β亚基中。尽管这些位点与折叠,运输,发炎和宿主防御以及先天性糖基化疾病(CDG)有关,但在糖蛋白表征中并不总是占据这些位点,并且经常忽略其占据。与三种广泛使用的生物药物hTSH的三种重组制剂相比,N-糖基分析分析首次用于两种天然垂体hTSH的位点占有率测定。单一方法提供了:(i)平均N-聚糖质量; (ii)每种单糖和硫酸盐的质量分数; (iii)碳水化合物百分比。结果表明,重组激素的占有率(65%–87%)和碳水化合物质量(12%–19%)可高达34%–57%。垂体hTSH中的平均聚糖质量降低了24%,并且所含的半乳糖(p <0.005)和唾液酸(p <0.01)减少了约3倍。具有最小的聚糖质量和最低的占有率以及GalNAc,硫酸盐,Gal和唾液酸含量的两种天然制剂之一也具有最低的体内生物活性和循环半衰期。所描述的将重组生物药物与其天然等同物进行比较的方法可以应用于任何生理或临床相关的糖蛋白。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号